Correlation Between Oncotelic Therapeutics and GeneThera
Can any of the company-specific risk be diversified away by investing in both Oncotelic Therapeutics and GeneThera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncotelic Therapeutics and GeneThera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncotelic Therapeutics and GeneThera, you can compare the effects of market volatilities on Oncotelic Therapeutics and GeneThera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncotelic Therapeutics with a short position of GeneThera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncotelic Therapeutics and GeneThera.
Diversification Opportunities for Oncotelic Therapeutics and GeneThera
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oncotelic and GeneThera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncotelic Therapeutics and GeneThera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneThera and Oncotelic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncotelic Therapeutics are associated (or correlated) with GeneThera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneThera has no effect on the direction of Oncotelic Therapeutics i.e., Oncotelic Therapeutics and GeneThera go up and down completely randomly.
Pair Corralation between Oncotelic Therapeutics and GeneThera
If you would invest 0.01 in GeneThera on September 14, 2024 and sell it today you would earn a total of 0.00 from holding GeneThera or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Oncotelic Therapeutics vs. GeneThera
Performance |
| Timeline |
| Oncotelic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| GeneThera |
Oncotelic Therapeutics and GeneThera Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncotelic Therapeutics and GeneThera
The main advantage of trading using opposite Oncotelic Therapeutics and GeneThera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncotelic Therapeutics position performs unexpectedly, GeneThera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneThera will offset losses from the drop in GeneThera's long position.| Oncotelic Therapeutics vs. Processa Pharmaceuticals | Oncotelic Therapeutics vs. Advanced Proteome Therapeutics | Oncotelic Therapeutics vs. Cellectis SA | Oncotelic Therapeutics vs. ChitogenX |
| GeneThera vs. Rigel Pharmaceuticals | GeneThera vs. Geron | GeneThera vs. Verastem | GeneThera vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |